CXCL14 expression level in patients with COAD was downregulated in (1) sex (male), (2) pathological stage (stage 2), and (3) sample type (COAD) (P < 0.05) (Figures 1(j1)–1(j3)). This evidence concerns the gene CXCL14 and colon adenocarcinoma.